Long Ideas - Shares of ARIAD Pharmaceuticals (NASDAQ:ARIA) have been moving sporadically in the last week as traders test the limits of its latest range; ARIA set a … Continue Reading
Read nowLong Ideas - Novabay Pharmaceuticals (AMEX:NBY) could trade up today after the company announced the receipt of a $2.6M milestone payment from its development and marketing partner, Galderma … Continue Reading
Read nowLong Ideas - Sucampo Pharmaceuticals (NASDAQ:SCMP) announced with its partner Takeda Pharmaceuticals that the FDA has granted priority review for its sNDA (supplemental new drug application) for Amitiza … Continue Reading
Read nowInterviews - As the second-most prevalent cancer in the U.S. and 3rd leading cause of death, colorectal cancer and its treatment present a major market for Spectrum … Continue Reading
Read nowInterviews - Clinical trials and in-house drug development are expensive and time-consuming aspects of the biotechnology industry, but are nevertheless fixtures of standard business development. SciClone Pharmaceuticals … Continue Reading
Read nowLong Ideas - Shares of Pain Therapeutics (NASDAQ:PTIE) continue to rise as partner Pfizer (NYSE:PFE) continues to send signals that Remoxy’s New Drug Application (NDA) could be resubmitted … Continue Reading
Read nowMost Popular - Savient Pharmaceuticals (NASDAQ:SVNT) got a bump on Monday, up 16% to $2.92, following an announcement that John Hamill will be filling the company’s vacant CFO … Continue Reading
Read now